Anticholinergic Practice May Not Affect Tardive Dyskinesia
While withdrawal of anticholinergic drugs has been investigated in the past to improve TD symptoms, evidence is weak for arguments in favor and against the drug class for TD.
Read More
How Can Baby Boomers Become More HCV Aware?
Former flaws in medical care may have driven the generation's rate of infection, but modern testing will improve it.
Weak Evidence for Vitamin E as Tardive Dyskinesia Treatment
There is some evidence that taking branched chain neutral amino acids may help TD.
DAAs Make Possible Transplant of HCV Positive Organs
DAAs have made the risk of HCV infection both manageable and ethically acceptable.
Channel Blockers Show Promise of New HCV Treatment
Researchers used molecular genetic and biochemical approaches to understand the capacity of a virus to create and use pores punched through the cell membrane.
Possible Obstacle to HIV 'Kick and Kill' Method Found
New research investigating a novel means to eradicate HIV found a significant roadblock on the way to a cure.
New Multi-Drug Resistant Infection Guidelines Released
While maintaining contact precautions for extended periods can keep from spreading, unnecessarily long isolation can negatively impact care.
Future of FMT May Depend on New AGA Registry
The first participant has been enrolled in the American Gastroenterological Association’s (AGA) FMT study, planned to be the largest of its kind.
Effectiveness of Fidaxomicin Versus Vancomycin for Clostridium Difficile Treatment
Extended-pulsed fidaxomicin proved superior to standard vancomycin therapy for sustained clinical cure after 30 days.
Children Exposed to Drugs, Violence Experience Higher Incidence of HIV as Adults
Can the social and psychological traumas experienced as a teenager increase the likelihood of behavior in later adulthood that risks HIV infection?
